NO20004313L - Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer - Google Patents

Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer

Info

Publication number: NO20004313L
Authority: NO; Norway
Prior art keywords: preparation; lipoxygenase inhibitors; formula; heterocyclic ring; ring systems
Prior art date: 1999-08-31

Application number

NO20004313A

Other languages

English (en)

Norwegian (no)

Other versions

NO20004313D0 (no

Inventor

Timothy Norris

John Francis Lambert

Megan Elizabeth Hnatow

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-31

Filing date

2000-08-30

Publication date

2001-03-01

2000-08-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-08-30 Publication of NO20004313D0 publication Critical patent/NO20004313D0/no

2001-03-01 Publication of NO20004313L publication Critical patent/NO20004313L/no

Links

239000000867 Lipoxygenase Inhibitor Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
125000000623 heterocyclic group Chemical group 0.000 title 1
239000011541 reaction mixture Substances 0.000 abstract 2
239000011734 sodium Substances 0.000 abstract 2
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
229910052792 caesium Inorganic materials 0.000 abstract 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000010438 heat treatment Methods 0.000 abstract 1
229910052744 lithium Inorganic materials 0.000 abstract 1
239000012299 nitrogen atmosphere Substances 0.000 abstract 1
229910052700 potassium Inorganic materials 0.000 abstract 1
239000011591 potassium Substances 0.000 abstract 1
229910052701 rubidium Inorganic materials 0.000 abstract 1
IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrane Compounds (AREA)

NO20004313A 1999-08-31 2000-08-30 Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer NO20004313L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US15161599P	1999-08-31	1999-08-31

Publications (2)

Publication Number	Publication Date
NO20004313D0 NO20004313D0 (no)	2000-08-30
NO20004313L true NO20004313L (no)	2001-03-01

Family

ID=22539529

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004313A NO20004313L (no)	1999-08-31	2000-08-30	Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer

Country Status (33)

Country	Link
US (1)	US6346624B1 (is)
EP (1)	EP1081143A1 (is)
JP (1)	JP2001106682A (is)
KR (1)	KR20010050256A (is)
CN (1)	CN1286250A (is)
AP (1)	AP2000001910A0 (is)
AU (1)	AU5360300A (is)
BG (1)	BG104731A (is)
BR (1)	BR0003945A (is)
CA (1)	CA2317097A1 (is)
CZ (1)	CZ20003158A3 (is)
EA (1)	EA200000801A1 (is)
EE (1)	EE200000512A (is)
GT (1)	GT200000142A (is)
HR (1)	HRP20000564A2 (is)
HU (1)	HUP0003439A3 (is)
ID (1)	ID27129A (is)
IL (1)	IL138087A0 (is)
IS (1)	IS5603A (is)
MA (1)	MA26751A1 (is)
NO (1)	NO20004313L (is)
NZ (1)	NZ506632A (is)
OA (1)	OA11452A (is)
PA (1)	PA8499701A1 (is)
PE (1)	PE20010520A1 (is)
PL (1)	PL342281A1 (is)
SG (1)	SG87146A1 (is)
SK (1)	SK12872000A3 (is)
SV (1)	SV2002000159A (is)
TN (1)	TNSN00177A1 (is)
TR (1)	TR200002529A2 (is)
UY (1)	UY26314A1 (is)
ZA (1)	ZA200004435B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6669042B1 (en) *	2002-09-30	2003-12-30	Hewlett-Packard Development Company, L.P.	Integrated positioning and locking device
US7674811B2 (en)	2006-03-14	2010-03-09	Ranbaxy Laboratories Limited	5-lipoxygenase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5883106A (en) *	1994-10-18	1999-03-16	Pfizer Inc.	5-lipoxygenase inhibitors
SK281577B6 (sk)	1994-10-18	2001-05-10	Pfizer Inc.	Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
US6063928A (en) *	1994-10-18	2000-05-16	Pfizer Inc	5-lipoxygenase inhibitors
US6239285B1 (en) *	1998-02-06	2001-05-29	Pfizer Inc	Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems

2000
- 2000-06-29 US US09/607,011 patent/US6346624B1/en not_active Expired - Fee Related
- 2000-08-01 SG SG200004341A patent/SG87146A1/en unknown
- 2000-08-10 PA PA20008499701A patent/PA8499701A1/es unknown
- 2000-08-16 EP EP00307014A patent/EP1081143A1/en not_active Withdrawn
- 2000-08-18 OA OA1200000225A patent/OA11452A/en unknown
- 2000-08-24 AU AU53603/00A patent/AU5360300A/en not_active Abandoned
- 2000-08-24 IL IL13808700A patent/IL138087A0/xx unknown
- 2000-08-25 SK SK1287-2000A patent/SK12872000A3/sk unknown
- 2000-08-25 IS IS5603A patent/IS5603A/is unknown
- 2000-08-28 ID IDP20000711A patent/ID27129A/id unknown
- 2000-08-28 ZA ZA200004435A patent/ZA200004435B/xx unknown
- 2000-08-28 GT GT200000142A patent/GT200000142A/es unknown
- 2000-08-28 UY UY26314A patent/UY26314A1/es not_active Application Discontinuation
- 2000-08-29 JP JP2000259063A patent/JP2001106682A/ja active Pending
- 2000-08-29 PE PE2000000885A patent/PE20010520A1/es not_active Application Discontinuation
- 2000-08-29 BG BG104731A patent/BG104731A/xx unknown
- 2000-08-29 CA CA002317097A patent/CA2317097A1/en not_active Abandoned
- 2000-08-30 NZ NZ506632A patent/NZ506632A/en unknown
- 2000-08-30 HR HR20000564A patent/HRP20000564A2/hr not_active Application Discontinuation
- 2000-08-30 HU HU0003439A patent/HUP0003439A3/hu unknown
- 2000-08-30 KR KR1020000050608A patent/KR20010050256A/ko not_active Abandoned
- 2000-08-30 TN TNTNSN00177A patent/TNSN00177A1/fr unknown
- 2000-08-30 MA MA26054A patent/MA26751A1/fr unknown
- 2000-08-30 NO NO20004313A patent/NO20004313L/no not_active Application Discontinuation
- 2000-08-30 SV SV2000000159A patent/SV2002000159A/es unknown
- 2000-08-30 CN CN00126408A patent/CN1286250A/zh active Pending
- 2000-08-30 CZ CZ20003158A patent/CZ20003158A3/cs unknown
- 2000-08-30 EA EA200000801A patent/EA200000801A1/ru unknown
- 2000-08-31 TR TR2000/02529A patent/TR200002529A2/xx unknown
- 2000-08-31 PL PL00342281A patent/PL342281A1/xx not_active Application Discontinuation
- 2000-08-31 AP APAP/P/2000/001910A patent/AP2000001910A0/en unknown
- 2000-08-31 EE EEP200000512A patent/EE200000512A/xx unknown
- 2000-08-31 BR BR0003945-4A patent/BR0003945A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR0003945A (pt)	2001-04-03
KR20010050256A (ko)	2001-06-15
EE200000512A (et)	2001-04-16
BG104731A (en)	2001-09-28
IS5603A (is)	2001-03-01
UY26314A1 (es)	2001-04-30
HUP0003439A3 (en)	2002-08-28
SK12872000A3 (sk)	2001-11-06
NO20004313D0 (no)	2000-08-30
CA2317097A1 (en)	2001-02-28
CN1286250A (zh)	2001-03-07
SG87146A1 (en)	2002-03-19
ZA200004435B (en)	2002-02-28
OA11452A (en)	2003-12-08
PL342281A1 (en)	2001-03-12
TR200002529A2 (tr)	2001-04-20
HUP0003439A2 (hu)	2001-08-28
SV2002000159A (es)	2002-01-23
NZ506632A (en)	2002-02-01
AP2000001910A0 (en)	2000-09-30
TNSN00177A1 (fr)	2005-11-10
CZ20003158A3 (cs)	2001-09-12
EA200000801A1 (ru)	2001-04-23
HU0003439D0 (en)	2000-08-30
HRP20000564A2 (en)	2001-12-31
MA26751A1 (fr)	2004-12-20
PA8499701A1 (es)	2001-12-14
JP2001106682A (ja)	2001-04-17
AU5360300A (en)	2001-03-08
PE20010520A1 (es)	2001-04-28
ID27129A (id)	2001-03-01
GT200000142A (es)	2002-02-19
US6346624B1 (en)	2002-02-12
IL138087A0 (en)	2001-10-31
EP1081143A1 (en)	2001-03-07

Legal Events

Date	Code	Title	Description
2003-04-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ES433835A1 (es)	1976-11-16	Un procedimiento de obtencion de un compuesto de piridini- loxi (tio) fenilurea.
MX154758A (es)	1987-12-10	Procedimiento para preparacion de derivados de succinimida
DK0498721T3 (da)	2000-06-26	Nye N-substituerede quinolinforbindelser, fremgangsmåde til deres fremstilling, mellemprodukter deraf, deres anvendelse som
TR200000993T2 (tr)	2000-12-21	Endotelin antagonistleri.
AU5443086A (en)	1986-09-11	Beta-lactam antibiotics, process for their preparation and their use as and in medicaments
IE33124B1 (en)	1974-03-20	New heterocyclic carboxylic acids their derivatives and use
NZ210100A (en)	1988-06-30	5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepine derivatives and pharmaceutical compositons
NO20004313L (no)	2001-03-01	Fremgangsmåte for fremstilling av 5-lipoksygenase-inhibitorer med varierte heterocycliske ringsystemer
ES2001703A6 (es)	1988-06-01	Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
JPS5392767A (en)	1978-08-15	Preparation of 2-phthalimidomethylindole derivatives
IL145449A0 (en)	2002-06-30	Processes for preparing pesticidal intermediates
DK118386D0 (da)	1986-03-14	Beta-lactam-antibiotika, deres fremstilling og anvendelse som laegemidler
JPS51128982A (en)	1976-11-10	New corbostyril derivatives and pharmaceutical compositions containing thereof
SE7607038L (sv)	1976-12-22	Nya antidiabetiskt aktiva isooxazolderivat
DK591185A (da)	1986-06-20	Fremgangsmaade til fremstilling af aminothiazoleddikesyrederivater
HRP960369B1 (en)	2009-05-31	Process for the preparation of epoxide
NO931871L (no)	1993-11-29	Detergentblanding og anvendelse derav
ES472295A1 (es)	1979-02-16	Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica
IE33065L (en)	1969-10-26	Camphoryl sulphonyl urea derivatives
JPS5392766A (en)	1978-08-15	Preparation of 2-aminomethylindole derivatives
GB905778A (en)	1962-09-12	Improvements in or relating to penicillins
JPS6487503A (en)	1989-03-31	Composition slowly releasing active oxygen
FI813088L (fi)	1982-04-07	Acylderivat
JPS53141110A (en)	1978-12-08	Ceillng structure of industrial ceramic furnace
JPS532476A (en)	1978-01-11	Synthesis of 4-substituted-dithio-2-azetidinone derivatives